1Corash L. Measurement of platelet activation by fluorescence activated flow cytometry. Blood Cell, 1999,16 : 97.
2Metzelaar MJ,Wijngaard PL, Peters PJ, et al. CDSsantigen, a novel lysosmal membrane glycoprotein cloned by a screening procedur for intracellular antigens in eukaryotic cells . J Biol Chem, 2000,70,838.
3American Heart Association.Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism[J].Circulation,2007;116(13):1497-503.
4Glynn RJ,Ridker PM,Goldhaber SZ,et al.Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism:report from the Women′s Health Study[J].Circulation,2008;117(15):1312-3.
5Lee IM,Cook NR,Gaziano JM,et al.Vitamin E in the primary prevention of cardiovascular disease and cancer:the Women′s Health Study:a randomized controlled trial[J].JAMA,2005;294:56-65.
6Booth SL,Golly I,Sacheck JM,et al.Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status[J].Am J Clin Nutr,2004;80:143-8.
7Joseph A,Vita MD,Monika Holbrook,et al.Flow-induced arterial remodeling relates to endothelial function in the human forearm[J].Circulation,2008;117(24):3126-33.
8Andreozzi GM.Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency[J].Minerva Cardioangiol,2007;55(6):741-53.
9Lowe GDO.Risk and prophylaxis for venous thromboembolism in hospital patients[J].BMU,2002;315:567.
10Tupie A G.Prophylaxis of venous thromboembolism in stroke patients[J].Semin ThrombHemost,1997,23(2):155.
